Stocksigma LogoStocksigma Logo

Chandan Healthcare Reports Strong H1 FY27 Results and Divests Pharmacy Stake

For H1 FY27, Chandan Healthcare reported standalone total income of Rs 109.12 Cr, up 40.56% YoY, while EBITDA rose 66.52% YoY to Rs 40.31 Cr with margins

Chandan Healthcare Reports Strong H1 FY27 Results and Divests Pharmacy Stake

Chandan Healthcare Ltd 路 Press Release 路 18 Nov 2026, 12:45 am

Chandan Healthcare Reports Strong H1 FY27 Results and Divests Pharmacy Stake For H1 FY27, Chandan Healthcare reported standalone total income of Rs 109.12 Cr, up 40.56% YoY, while EBITDA rose 66.52% YoY to Rs 40.31 Cr with margins at 36.95%. Net profit jumped 256.72% YoY to Rs 25.37 Cr, supported by an exceptional net gain of Rs 10.23 Cr from divesting its 53.56% stake in Chandan Pharmacy for Rs 16.77 Cr. The franchise network expanded to 685 centres, targeting 1,000 by FY27-end. Additionally, it entered Ghaziabad by acquiring two Ansh Diagnostics units in Indirapuram.

Original exchange filing (PDF)

More announcements from Chandan Healthcare Ltd

All Chandan Healthcare Ltd announcements